<DOC>
	<DOCNO>NCT00480298</DOCNO>
	<brief_summary>This study double-blinded , randomize , placebo control , multi-center trial 120 subject nasal polyposis ( NP ) treat 20 day oral corticosteroid ( OCS ) decrease dose oral doxycyclin ( ODOX ) placebo . At visit clinical biological activity assess nasal peak inspiratory flow ( nPIF ) , symptom , olfactory test , endoscopic evaluation nasal polyp , peripheral eosinophil level marker inflammation IL-5 , IL-5 receptor alpha , ECP , TGFÎ²1 , IgE specific IgE serum nasal secretion .</brief_summary>
	<brief_title>Double-Blind Randomized Placebo-Controlled Trial Clinical Biological Effects Oral Corticosteroids Doxycyclin Patients With Nasal Polyposis</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Subjects must least 18 year age , either sex race . Subjects must diagnosis bilateral nasal polyp Screening Baseline recur surgical resection nasal polyp Grades 3 4 naris . Subjects must good health , free clinically significant disease would interfere study schedule procedure compromise his/her safety . Subjects must willing give informed consent adhere visit schedule , medication restriction , agree perform daily diary entry . Subjects concurrent asthma must maintain 1000 mcg/day BDP equivalent Nonpregnant woman childbearing potential must use medically acceptable , adequate form birth control . This include : ) hormonal contraceptive prescribe physician ( eg , oral combine , hormonal implant , depot injectable ) ; b ) medically prescribed IUD ; c ) condom combination spermicide ; ) monogamous relationship male partner vasectomy use condom plus spermicide study . They must start birth control method least three month prior Screening ( exception condom combination spermicide ) , must agree continue use duration study . Women childbearing potential currently sexually active must agree consent use doublebarrier method become sexually active course study . Women surgically sterilize least one year postmenopausal consider childbearing potential . However , female subject must urine pregnancy test prior treatment , must negative . Male subject must agree use adequate form birth control duration study . They must either agree use condom spermicide agree sexual relation woman use medically acceptable form birth control described Women must pregnant , breast feeding , premenarcheal . Subjects require burst oral corticosteroid within previous three month prior Screening exclude study . Subjects systemic fungoid infection , know allergic reaction methylprednisolon tetracycline , hypertension , diabetes ( type 1 2 ) , glaucoma , child , tuberculosis , herpes infection , zona oftalmica . Subjects acute sinusitis , concurrent nasal infection , subject nasal upper respiratory tract infection within two week Screening Visit exclude . Subjects cystic fibrosis , primary ciliary 's dysfunction Kartagener 's syndrome history exclude . Subjects must diagnose parasitic infection . Subjects must know HIV positive positive hepatitis B surface antigen C antibody . Testing do Screening . Subjects must acute asthmatic attack require admission hospital ( exclude emergency room visit result direct discharge without hospitalization ) within four week prior Screening . Subjects must receive immunotherapy within previous three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>